Crohn's disease recurrence in a small bowel transplant

American Journal of Gastroenterology

Volumn 99, Issue 1, 2004, Pages 158-162

  Kaila, Brinderjit ^b   Grant, David ^b   Pettigrew, Norman ^b   Greenberg, Howard ^b   Bernstein, Charles N ^a  

^a John Buhler Research Centre   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BICARBONATE; CORTICOSTEROID; DIPHENOXYLATE; KREON; MAJOR HISTOCOMPATIBILITY ANTIGEN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; HUMAN; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; KIDNEY FAILURE; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SMALL INTESTINE; PATHOLOGY; TRANSPLANTATION;

ADULT; CROHN DISEASE; HUMANS; INTESTINE, SMALL; MALE; RECURRENCE;

EID: 1542493308     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1572-0241.2003.04004.x     Document Type: Article

References (19)

1. Murray JJ, Schoetz DJ, Nugent FW, et al. Surgical Management of Crohn's disease involving the duodenum. Am J Surg 1984;147:58-71.
2. Krupnick AS, Morris JB. The long-term results of resection and multiple resections in Crohn's disease. Sem Gastrointest Dis 2000;11:41-51.
3. International Intestinal Transplantation Registry, August 26, 2002, www.intestinaltransplant.org
4. Sustento-Roedica N, Ruiz P, Rogers A, et al. Recurrent Crohn's disease in transplanted bowel. Lancet 1997;349:688-91.
5. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
6. Malizia G, Calabrese A, Cottone M, et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991;100:150-9.
7. Iwaki Y, Starzl TE, Yagihashi A, et al. Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991;1:818-9.
8. Papatheodoridis GV, Hamilton M, Mistry PK, et al. Ulcerative colitis has an aggressive course after orthoscopic liver transplantation for primary sclerosing cholangitis. Gut 1998;43:639-44.
9. Brynskov J, Freund L, Norby Rasmussen S, et al. Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease. Scand J Gastroenterol 1991;26:689-95.
10. Jewell DP, Lennard-Jones JE. Cyclosporin Study Group of Great Britain and Ireland. Oral cyclosporin for chronic active Crohn's disease: a multicentre controlled trial. Eur J Gastroenterol Hepatol 1994;6:499-505.
11. Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double-blind, randomized trial of cyclosporin therapy in active Crohn's disease. N Eng J Med 1989;321:845-50.
12. Feagen BG, McDonald JWD, Rochon J, et al. Low-dose cyclosporin for the treatment of Crohn's disease. N Eng J Med 1994;330:1846-51.
13. Zhu J, McKeon F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature 1999; 398:256-60.
14. Pearson DC, May GR, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
15. Bernstein CN, Blanchard JF. Epidemiology of inflammatory bowel disease. In: Cohen RD, ed. Clinical gastroenterology: Inflammatory bowel disease: Diagnosis and therapeutics. Totowa, NJ: Humana Press Inc., 2002.
16. Cuillerier E, Lemann M, Bouhnik Y, et al. Azathioprine for prevention of postoperative recurrence in Crohn's disease: A retrospective study. Eur J Gastroenterol Hepatol 2001;13:1291-6.
17. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-73.
18. Korelitz B, Hanauer S, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA, or placebo in Crohn's disease: A 2-year multicenter trial. Gastroenterology 1998;114:A1011.
19. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review. Gut 2002;50:485-9.